In our investigation, we reported that serum ADAM15 concentrations were higher in CRC patients compared to healthy controls, similar to the classical tumor markers and CRP; however, significant differences were only observed for CEA and CRP. This evidence concerns the gene CEACAM5 and neoplasm.